Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of “Moderate Buy” from Brokerages

Agilent Technologies, Inc. (NYSE:AGet Free Report) has received a consensus recommendation of “Moderate Buy” from the nineteen research firms that are covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $159.3529.

Several equities analysts have recently issued reports on A shares. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their target price for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Royal Bank Of Canada assumed coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective for the company. Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target on the stock. Finally, Robert W. Baird raised their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th.

Check Out Our Latest Research Report on Agilent Technologies

Institutional Trading of Agilent Technologies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bridgefront Capital LLC acquired a new stake in shares of Agilent Technologies in the third quarter valued at about $1,323,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after purchasing an additional 24,687 shares during the period. AIA Group Ltd bought a new stake in shares of Agilent Technologies in the 3rd quarter worth about $2,475,000. Massachusetts Financial Services Co. MA grew its holdings in shares of Agilent Technologies by 13.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. Finally, CCLA Investment Management boosted its position in shares of Agilent Technologies by 1.9% during the fourth quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock worth $142,542,000 after buying an additional 19,518 shares during the period.

Agilent Technologies Stock Down 3.5%

A opened at $131.34 on Monday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $37.09 billion, a price-to-earnings ratio of 26.37, a P/E/G ratio of 2.42 and a beta of 1.25. The business has a 50 day moving average of $127.49 and a 200-day moving average of $125.63. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $160.27.

Agilent Technologies (NYSE:AGet Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the business earned $1.31 EPS. The firm’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts anticipate that Agilent Technologies will post 6 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 20.48%.

About Agilent Technologies

(Get Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Read More

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.